| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.6 |